Kieran MW

ORCID: 0000-0003-2184-7692 · 2 papers in corpus

2024

Patterns of expression of VEGFR2, PDGFRs and c-Kit in pediatric patients with high grade non-rhabdomyosarcoma soft tissue sarcoma.

Frontiers in oncology ·doi:10.3389/fonc.2024.1480773

IntroductionActivated vascular endothelial growth factor receptors (VEGFRs), platelet-derived growth factor receptors (PDGFRs) and c-Kit have been shown to be involved in the growth, invasion and metastasis of non-rhabdomyosarcoma soft tiss…

2010

Inhibition of tumor angiogenesis by oral etoposide.

Experimental and therapeutic medicine ·doi:10.3892/etm.2010.127

The chemotherapeutic agent etoposide is a topoisomerase II inhibitor widely used for cancer therapy. Low-dose oral etoposide, administered at close regular intervals, has potent anti-tumor activity in patients who are refractory to intraven…